Rebecca (Becky) Richards

Rebecca (Becky) Richards

Pediatrics

Engineering next-generation CAR-T cells for blood cancers

WIMR 4153
1111 Highland Avenue
Madison, WI 53705

Rebecca (Becky) Richards

LAB WEBSITE:

Richards Lab

FOCUS GROUPS:

Cancer Biology; Immunology

RESEARCH DESCRIPTION:

I am a physician-scientist and joined the University of Wisconsin–Madison as faculty in 2022. The overarching goal of my research is to advance immunotherapeutic options for pediatric cancer patients. My lab focuses on developing chimeric antigen receptor T (CAR-T) cells specific for acute myeloid leukemia (AML), a disease that can be difficult to treat and is associated with many treatment-related toxicities. CAR-T cell therapy has revolutionized treatment for patients with B cell malignancies, and is an attractive option for treatment of AML. Despite promising pre-clinical data, translation to patients has been hampered by tumor heterogeneity and the possibility of on-target, off-tumor toxicity to healthy tissues. My lab employs next-generation engineering to endow CAR-T cells with improved tumor specificity, and we seek to define mechanisms of CAR-T cell signaling and target tumor cell resistance. We will use pre-clinical models to identify critical components of AML tumor cell and CAR-T cell biology that will inform further clinical development.

PERFORM A PUBMED PUBLICATION SEARCH